Related Experiment Video
Updated: Mar 29, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Current and Evolving Treatments of Genotype 1 Hepatitis C Virus
Saleh Alqahtani1, Mark Sulkowski1
1Department of Medicine, The Johns Hopkins Hospital, 1830 East Monument Street, Suite 427, Baltimore, MD 21287, USA.
Abstract:
Development of antiviral agents that target the hepatitis C virus (HCV) has improved the success and tolerability of treatment, especially for patients with HCV genotype 1 infection. The new treatment options mean that clinicians are better able to prevent complications from chronic HCV infection. The field of direct-acting antiviral therapies for HCV infection continues to advance at a rapid pace, and many more potential treatment regimens are being investigated. This article presents a summary of the current treatments available for patients infected with HCV genotype 1 and looks ahead to those that may play a role in the future.
More Related Videos
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Related Concept Videos
Hepatitis
Inhibitors of Viral Protein Synthesis
Retrovirus Life Cycles
Pharmacogenomics: Identification of New Drug Targets
Cystic Fibrosis: Management
Sinus disease and chronic...
Microorganisms in Medicine and Therapeutics